《美國股市》道指跌逾百點 中資科網股領升
投資者擔心美聯儲在通脹放緩下繼續加息,美國股市連續第二天下跌。道指開市跌125點或0.38%,報33,171.35點。納指跌66點或0.61%,報10,890.4點;標普500指數跌17點或0.43%,報3,911.84點。
中資科技股領升,拼多多(PDD.US)、百度(BIDU.US)升超過3%,京東(JD.US)升2.8%,三隻均為納指最佳表現股。
寶潔(PG.US)下跌逾1%,寶潔第二財季調整後每股收益為1.59美元,符合預期,總收入為207.7億美元,略高於預期的207.3億美元。蘋果(AAPL.US)跌0.2%,摩通下調蘋果目標價,指因供應受限,難以盈利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.